Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination rFVIIa and FEIBA for Hemophilia A with Inhibitors
NCT00284193Phase 4Completed
- Sponsor
- Sheba Medical Center
- Start
- Jan 2005
- Primary completion
- Nov 2008
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of coagulation factor VIIa, anti-inhibitor coagulant complex in hemophilia A, sponsored by Sheba Medical Center. Started Jan 2005; status: completed.
02
Drugs
coagulation factor VIIaanti-inhibitor coagulant complex
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00284193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00284193.